Kirr Marbach & CO LLC Biogen Inc. Transaction History
Kirr Marbach & CO LLC
- $413 Million
- Q3 2024
A detailed history of Kirr Marbach & CO LLC transactions in Biogen Inc. stock. As of the latest transaction made, Kirr Marbach & CO LLC holds 34,376 shares of BIIB stock, worth $5.43 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
34,376
Previous 34,232
0.42%
Holding current value
$5.43 Million
Previous $7.94 Million
16.03%
% of portfolio
1.61%
Previous 2.08%
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,036Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.63 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.58 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.3 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.16 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$810 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...